European Review for Medical and Pharmacological Sciences

European Review for Medical
and Pharmacological Sciences

European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research.

The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine.

We encourage scientists from all around the world to submit their research regarding PACS (Post-Acute COVID-19 Syndrome).
Any contribution is important for the Scientific Community.

The full text of the articles can be downloaded free of charge.

Indexed in PubMed

CiteScore: 6.3

Issues Archive - Page 316

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4807-4814
DOI: 10.26355/eurrev_201906_18066

MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4

M. Zhang, H. Shi, C. Zhang, S.-Q. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4800-4806
DOI: 10.26355/eurrev_201906_18065

LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer

D.-J. Yu, Y.-H. Li, M. Zhong
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4793-4799
DOI: 10.26355/eurrev_201906_18064

Long noncoding RNA HOXA-AS2 promotes cell migration and invasion via upregulating IGF-2 in non-small cell lung cancer as an oncogene

F.-X. Zheng, X.-Q. Wang, W.-X. Zheng, J. Zhao
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4784-4792
DOI: 10.26355/eurrev_201906_18063

JMJD3 enhances invasiveness and migratory capacity of non-small cell lung cancer cell via activating EMT signaling pathway

Y. Zhang, P.-Y. Hua, C.-Y. Jin, J.-D. Li, G.-X. Zhang, B. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4777-4783
DOI: 10.26355/eurrev_201906_18060

Long noncoding RNA CASC2 alleviates the growth, migration and invasion of oral squamous cell carcinoma via downregulating CDK1

H.-B. Xing, H.-M. Qiu, Y. Li, P.-F. Dong, X.-M. Zhu
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4770-4776
DOI: 10.26355/eurrev_201906_18059

LncRNA LUCAT1 promotes rowth, migration, and invasion of oral squamous cell carcinoma by upregulating PCNA

Y. Kong, Y. Feng, Y.-Y. Xiao, S.-C. Liu, X.-G. Li, Q.-L. Yang, W.-H. Chu, J.-G. Liu
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4763-4769
DOI: 10.26355/eurrev_201906_18058

MiRNA-93-5p promotes the biological progression of gastric cancer cells via Hippo signaling pathway

H. Meng, Y.-Y. Li, D. Han, C.-Y. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4756-4762
DOI: 10.26355/eurrev_201906_18057

Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A

J.-X. Ma, Y.-L. Yang, X.-Y. He, X.-M. Pan, Z. Wang, Y.-W. Qian
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4746-4755
DOI: 10.26355/eurrev_201906_18056

MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway

Y.-M. Li, X.-J. Li, H.-L. Yang, Y.-B. Zhang, J.-C. Li
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4680-4687
DOI: 10.26355/eurrev_201906_18049

Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression

B. Qu, A.-H. Zhao, X.-Z. Nie, R. Sui, M.-M. Du, L. Jiang, H.-L. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4673-4679
DOI: 10.26355/eurrev_201906_18047

LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma

J. Lin, L.-L. Nong, M.-Q. Li, F.-C. Yang, S.-H. Wang, M.-J. Liu
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4663-4672
DOI: 10.26355/eurrev_201906_18046

MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer

L. Zhang, X.-L. Liu, Z. Yuan, J. Cui, H. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2019; 23 (11): 4656-4662
DOI: 10.26355/eurrev_201906_18045

Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer

Y.-B. Gong, Y.-F. Zou
Free PDF Download

European Review for Medical
and Pharmacological Sciences

Issues Archive - Page 316

MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4

LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer

Long noncoding RNA HOXA-AS2 promotes cell migration and invasion via upregulating IGF-2 in non-small cell lung cancer as an oncogene

JMJD3 enhances invasiveness and migratory capacity of non-small cell lung cancer cell via activating EMT signaling pathway

Long noncoding RNA CASC2 alleviates the growth, migration and invasion of oral squamous cell carcinoma via downregulating CDK1

LncRNA LUCAT1 promotes rowth, migration, and invasion of oral squamous cell carcinoma by upregulating PCNA

MiRNA-93-5p promotes the biological progression of gastric cancer cells via Hippo signaling pathway

Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A

LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway

MicroRNA-375 accelerates the invasion and migration of colorectal cancer through targeting RECK

Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis

Effects of RXRα on proliferation and apoptosis of pancreatic cancer cells through TGF-β/Smad signaling pathway

LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103

Long noncoding RNA PANDAR promotes progression and predicts poor prognosis via upregulating ROCK1 in prostate cancer

LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis

MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway

Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression

LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma

MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer

Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer